Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-((2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl)methyl)-1h-1,2,4-triazole
2. R 28644
1. 60207-31-0
2. Madurox
3. Azaconazol
4. 1-((2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl)methyl)-1h-1,2,4-triazole
5. Azaconazolum
6. Azoconazole
7. R 28644
8. 1-[[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl]-1,2,4-triazole
9. R-28644
10. 1-[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-ylmethyl]-1h-1,2,4-triazole
11. Chebi:81898
12. R-28,644
13. 1h-1,2,4-triazole, 1-[[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl]-
14. 45683d94eu
15. Ncgc00166311-01
16. Azoconozole
17. 1h-1,2,4-triazole, 1-((2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl)methyl)-
18. Dsstox_cid_21613
19. Dsstox_rid_79786
20. Dsstox_gsid_41613
21. Azaconazole [ansi]
22. Azaconazole [usan:inn]
23. Azaconazol [inn-spanish]
24. Azaconazolum [inn-latin]
25. Cas-60207-31-0
26. Einecs 262-102-3
27. Brn 0822252
28. Rodewod
29. Unii-45683d94eu
30. Azaconazole [mi]
31. Azaconazole [inn]
32. Azaconazole (usan/inn)
33. Azaconazole [usan]
34. 1h-1,2,4-triazole, 1-((2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl)methyl)
35. Schembl21056
36. Zinc975
37. 5-26-01-00204 (beilstein Handbook Reference)
38. Chembl261627
39. Dtxsid3041613
40. Tox21_112407
41. Tox21_301852
42. Bdbm50375305
43. Akos015901790
44. Azaconazole 100 Microg/ml In Methanol
45. Azaconazole 10 Microg/ml In Cyclohexane
46. Ncgc00255470-01
47. Azaconazole 10 Microg/ml In Acetonitrile
48. Db-053555
49. Ft-0602857
50. 3-(isopropoxycarbonyl)phenylboronicacid
51. Azaconazole, Pestanal(r), Analytical Standard
52. C18701
53. D03023
54. R28644
55. 207a310
56. Sr-01000883713
57. Sr-01000883713-1
58. W-105272
59. Q15632846
60. 1-{1-[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]ethan-2-yl}-1h-1,2,4-triazole
Molecular Weight | 300.14 g/mol |
---|---|
Molecular Formula | C12H11Cl2N3O2 |
XLogP3 | 2.3 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 299.0228320 g/mol |
Monoisotopic Mass | 299.0228320 g/mol |
Topological Polar Surface Area | 49.2 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 315 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Azaconazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Azaconazole, including repackagers and relabelers. The FDA regulates Azaconazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Azaconazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Azaconazole supplier is an individual or a company that provides Azaconazole active pharmaceutical ingredient (API) or Azaconazole finished formulations upon request. The Azaconazole suppliers may include Azaconazole API manufacturers, exporters, distributors and traders.
Azaconazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Azaconazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Azaconazole GMP manufacturer or Azaconazole GMP API supplier for your needs.
A Azaconazole CoA (Certificate of Analysis) is a formal document that attests to Azaconazole's compliance with Azaconazole specifications and serves as a tool for batch-level quality control.
Azaconazole CoA mostly includes findings from lab analyses of a specific batch. For each Azaconazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Azaconazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Azaconazole EP), Azaconazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Azaconazole USP).
LOOKING FOR A SUPPLIER?